Table 1 Baseline Characteristics of the Study Patients According to Treatment Group.
Characteristic | Compression plus HL-EVLA-FS (N = 200) | Compression therapy alone (N = 177) | P-value |
|---|---|---|---|
Gender | 0.899§ | ||
Male | 97(48.5%) | 87(49.2%) | |
Female | 103(51.5%) | 90(50.8%) | |
Age | 60.6 ± 10.3 | 62.4 ± 12.2 | 0.124* |
Hospital stay | 11.2 ± 5.3 | 10.8 ± 5.7 | 0.479* |
BMI | 28.4 ± 2.69 | 28.4 ± 2.73 | 0.984* |
History of diabetes | 7(3.5%) | 6(3.4%) | 0.935§ |
Smoking history | 61(30.5%) | 55(31.1%) | 0.904§ |
Come from countryside | 170(85%) | 146(82.5%) | 0.508§ |
Course of varicose vein | 20.5 ± 12.4 | 22.3 ± 8.77 | 0.107* |
Ulcer duration | 25.3 ± 71.0 | 17.2 ± 41.3 | 0.169* |
Ulcer diameter | 3.09 ± 2.36 | 3.11 ± 1.72 | 0.920* |
Ulcer site | 0.626§ | ||
Right medial malleolus | 42(21%) | 35(19.8%) | |
Right lateral malleolus | 8(4%) | 12(6.8%) | |
Right foot boots area | 25(12.5%) | 20(11.3%) | |
Left medial malleolus | 81(40.5%) | 63(35.6%) | |
Left lateral malleolus | 11(5.5%) | 15(8.5%) | |
Left foot boots area | 33(16.5%) | 32(18.1%) | |
Venous reflux | |||
SDVR | 50(25.0%) | 46(26.0%) | 0.826§ |
FLDVR | 46(23.0%) | 40(22.6%) | 0.926§ |
CPV | 74(37.0%) | 65(36.7%) | 0.956§ |
SVR | 177(88.5%) | 157(88.7%) | 0.951§ |
ISVR | 70(37.0%) | 67(37.9%) | 0.565§ |
The VCSS of pre-intervention | 12.5 ± 3.31 | 12.2 ± 2.6 | 0.260* |
